1. Home
  2. ABCL
  3. ABCL News

Latest AbCellera Biologics Inc. (ABCL) News on May 9, 2025

AbCellera Biologics Inc (ABCL) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...
ABCL

GuruFocus.com

12 hours ago

AbCellera Biologics Inc (ABCL) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...

AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates
ABCL

Zacks

a day ago

AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Misses Revenue Estimates

AbCellera Reports Q1 2025 Business Results
ABCL

Business Wire

a day ago

AbCellera Reports Q1 2025 Business Results

AbCellera Biologics Inc (ABCL) Q1 2025 Earnings Report Preview: What To Look For
ABCL

GuruFocus.com

2 days ago

AbCellera Biologics Inc (ABCL) Q1 2025 Earnings Report Preview: What To Look For

AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025
ABCL

Business Wire

10 days ago

AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025

3 Promising Penny Stocks With Market Caps Up To $800M
ABCL

Simply Wall St.

16 days ago

3 Promising Penny Stocks With Market Caps Up To $800M

Is AbCellera Biologics Inc. (ABCL) the Best Canadian Penny Stock to Invest in Now?
ABCL

Insider Monkey

16 days ago

Is AbCellera Biologics Inc. (ABCL) the Best Canadian Penny Stock to Invest in Now?

AbCellera to Participate at Upcoming Investor Conferences in May and June
ABCL

Business Wire

a month ago

AbCellera to Participate at Upcoming Investor Conferences in May and June

AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025
ABCL

Business Wire

a month ago

AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025

AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025
ABCL

Business Wire

a month ago

AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025

Rapid Micro Biosystems And 2 Other Promising Penny Stocks To Consider
ABCL

Simply Wall St.

a month ago

Rapid Micro Biosystems And 2 Other Promising Penny Stocks To Consider

ABCL

Argus Research

2 months ago

Daily – Vickers Top Buyers & Sellers for 03/12/2025

AbCellera Biologics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
ABCL

Simply Wall St.

2 months ago

AbCellera Biologics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

ABCL

Thomson Reuters StreetEvents

2 months ago

Q4 2024 Abcellera Biologics Inc Earnings Call

AbCellera Biologics Inc (ABCL) Q4 2024 Earnings Call Highlights: Strategic Shifts Amid ...
ABCL

GuruFocus.com

2 months ago

AbCellera Biologics Inc (ABCL) Q4 2024 Earnings Call Highlights: Strategic Shifts Amid ...

AbCellera Biologics (ABCL) Q4 2024 Earnings Call Transcript
ABCL

Motley Fool

2 months ago

AbCellera Biologics (ABCL) Q4 2024 Earnings Call Transcript

AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Misses Revenue Estimates
ABCL

Zacks

2 months ago

AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Misses Revenue Estimates

AbCellera Reports Full Year 2024 Business Results
ABCL

Business Wire

2 months ago

AbCellera Reports Full Year 2024 Business Results

What To Expect From AbCellera Biologics Inc (ABCL) Q4 2024 Earnings
ABCL

GuruFocus.com

2 months ago

What To Expect From AbCellera Biologics Inc (ABCL) Q4 2024 Earnings

US Penny Stocks To Watch In February 2025
ABCL

Simply Wall St.

3 months ago

US Penny Stocks To Watch In February 2025

ABCL

MT Newswires

3 months ago

AbCellera Biologics Changes COO's Title to Technology Chief

One AbCellera Biologics Insider Raised Their Stake In The Previous Year
ABCL

Simply Wall St.

3 months ago

One AbCellera Biologics Insider Raised Their Stake In The Previous Year

AbCellera to Participate at Upcoming Investor Conferences in March
ABCL

Business Wire

3 months ago

AbCellera to Participate at Upcoming Investor Conferences in March

3 Promising US Penny Stocks With Market Caps Under $900M
ABCL

Simply Wall St.

4 months ago

3 Promising US Penny Stocks With Market Caps Under $900M

AbCellera to Report Full Year 2024 Financial Results on February 27, 2025
ABCL

Business Wire

4 months ago

AbCellera to Report Full Year 2024 Financial Results on February 27, 2025

AbCellera Biologics Inc. (NASDAQ:ABCL) most popular amongst individual investors who own 36% of the shares, institutions hold 29%
ABCL

Simply Wall St.

4 months ago

AbCellera Biologics Inc. (NASDAQ:ABCL) most popular amongst individual investors who own 36% of the shares, institutions hold 29%

AbCellera Biologics Inc. (ABCL): A Bull Case Theory
ABCL

Insider Monkey

4 months ago

AbCellera Biologics Inc. (ABCL): A Bull Case Theory

AbbVie and Simcere Zaiming link to develop trispecific antibody
ABCL

Pharmaceutical Technology

4 months ago

AbbVie and Simcere Zaiming link to develop trispecific antibody

AbCellera expands collaboration with AbbVie
ABCL

TipRanks

4 months ago

AbCellera expands collaboration with AbbVie

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology
ABCL

Business Wire

4 months ago

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology

ABCL

MT Newswires

4 months ago

KeyBanc Cuts Price Target on AbCellera Biologics to $4 From $5, Keeps Overweight Rating

Is AbCellera Biologics Inc. (ABCL) Among the Best Canadian Penny Stocks to Buy According to Analysts?
ABCL

Insider Monkey

4 months ago

Is AbCellera Biologics Inc. (ABCL) Among the Best Canadian Penny Stocks to Buy According to Analysts?

US Penny Stocks To Watch In December 2024
ABCL

Simply Wall St.

5 months ago

US Penny Stocks To Watch In December 2024

Is AbCellera Biologics (NASDAQ:ABCL) In A Good Position To Invest In Growth?
ABCL

Simply Wall St.

5 months ago

Is AbCellera Biologics (NASDAQ:ABCL) In A Good Position To Invest In Growth?

US Penny Stocks To Consider In November 2024
ABCL

Simply Wall St.

5 months ago

US Penny Stocks To Consider In November 2024

AbCellera to Present at Upcoming Investor Conferences in December and January
ABCL

Business Wire

6 months ago

AbCellera to Present at Upcoming Investor Conferences in December and January

AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024
ABCL

Business Wire

6 months ago

AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024

AbCellera Biologics Inc. (NASDAQ:ABCL) Just Reported And Analysts Have Been Cutting Their Estimates
ABCL

Simply Wall St.

6 months ago

AbCellera Biologics Inc. (NASDAQ:ABCL) Just Reported And Analysts Have Been Cutting Their Estimates

AbCellera Biologics Third Quarter 2024 Earnings: Misses Expectations
ABCL

Simply Wall St.

6 months ago

AbCellera Biologics Third Quarter 2024 Earnings: Misses Expectations

ABCL

Thomson Reuters StreetEvents

6 months ago

Q3 2024 Abcellera Biologics Inc Earnings Call

AbCellera Biologics Inc (ABCL) Q3 2024 Earnings Call Highlights: Navigating Challenges with ...
ABCL

GuruFocus.com

6 months ago

AbCellera Biologics Inc (ABCL) Q3 2024 Earnings Call Highlights: Navigating Challenges with ...

AbCellera Biologics (ABCL) Q3 2024 Earnings Call Transcript
ABCL

Motley Fool

6 months ago

AbCellera Biologics (ABCL) Q3 2024 Earnings Call Transcript

AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Misses Revenue Estimates
ABCL

Zacks

6 months ago

AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Misses Revenue Estimates

AbCellera Reports Q3 2024 Business Results
ABCL

Business Wire

6 months ago

AbCellera Reports Q3 2024 Business Results

AbCellera Biologics Inc (ABCL) Q3 2024: Everything You Need To Know Ahead Of Earnings
ABCL

GuruFocus.com

6 months ago

AbCellera Biologics Inc (ABCL) Q3 2024: Everything You Need To Know Ahead Of Earnings

AbCellera to Present at Upcoming Investor Conferences in November 2024
ABCL

Business Wire

7 months ago

AbCellera to Present at Upcoming Investor Conferences in November 2024

3 Promising Penny Stocks On US Exchanges With Over $600M Market Cap
ABCL

Simply Wall St.

7 months ago

3 Promising Penny Stocks On US Exchanges With Over $600M Market Cap

Is AbCellera Biologics Inc. (ABCL) the Penny Stock with the Biggest Upside Potential According to Analysts?
ABCL

Insider Monkey

7 months ago

Is AbCellera Biologics Inc. (ABCL) the Penny Stock with the Biggest Upside Potential According to Analysts?

AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024
ABCL

Business Wire

7 months ago

AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024

AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024
ABCL

Business Wire

7 months ago

AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024

AbCellera Biologics Inc. (ABCL): The Best Multibagger Penny Stock of 2025?
ABCL

Insider Monkey

8 months ago

AbCellera Biologics Inc. (ABCL): The Best Multibagger Penny Stock of 2025?

Carl Hansen Buys Handful Of Shares In AbCellera Biologics
ABCL

Simply Wall St.

8 months ago

Carl Hansen Buys Handful Of Shares In AbCellera Biologics

ABCL

Argus Research

8 months ago

Daily – Vickers Top Buyers & Sellers for 08/30/2024

AbCellera to Present at Upcoming Investor Conferences in September
ABCL

Business Wire

8 months ago

AbCellera to Present at Upcoming Investor Conferences in September

AbCellera Biologics Inc. (ABCL): A Top Contender Among Canada’s Best Penny Stocks in 2024
ABCL

Insider Monkey

8 months ago

AbCellera Biologics Inc. (ABCL): A Top Contender Among Canada’s Best Penny Stocks in 2024

ABCL

MT Newswires

9 months ago

Benchmark Downgrades AbCellera Biologics to Hold From Buy

Need To Know: The Consensus Just Cut Its AbCellera Biologics Inc. (NASDAQ:ABCL) Estimates For 2024
ABCL

Simply Wall St.

9 months ago

Need To Know: The Consensus Just Cut Its AbCellera Biologics Inc. (NASDAQ:ABCL) Estimates For 2024

Earnings Update: AbCellera Biologics Inc. (NASDAQ:ABCL) Just Reported And Analysts Are Trimming Their Forecasts
ABCL

Simply Wall St.

9 months ago

Earnings Update: AbCellera Biologics Inc. (NASDAQ:ABCL) Just Reported And Analysts Are Trimming Their Forecasts

AbCellera Biologics Inc.'s (NASDAQ:ABCL) latest 12% decline adds to one-year losses, institutional investors may consider drastic measures
ABCL

Simply Wall St.

9 months ago

AbCellera Biologics Inc.'s (NASDAQ:ABCL) latest 12% decline adds to one-year losses, institutional investors may consider drastic measures

AbCellera Biologics (ABCL) Q2 2024 Earnings Call Transcript
ABCL

Motley Fool

9 months ago

AbCellera Biologics (ABCL) Q2 2024 Earnings Call Transcript

AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Misses Revenue Estimates
ABCL

Zacks

9 months ago

AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Misses Revenue Estimates

AbCellera Reports Q2 2024 Business Results
ABCL

Business Wire

9 months ago

AbCellera Reports Q2 2024 Business Results

AbCellera and Lilly broadens antibody discovery partnership
ABCL

Pharmaceutical Technology

9 months ago

AbCellera and Lilly broadens antibody discovery partnership

ABCL

MT Newswires

9 months ago

AbCellera Biologics, Eli Lilly Expand Collaboration to Discover Antibody Therapies

AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines
ABCL

Business Wire

9 months ago

AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines

Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?
ABCL

Motley Fool

10 months ago

Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio?

ABCL

MT Newswires

10 months ago

--KeyBanc Adjusts Price Target on AbCellera Biologics to $5 From $7, Maintains Overweight Rating

AbCellera Biologics (ABCL) Upgraded to Buy: Here's What You Should Know
ABCL

Zacks

10 months ago

AbCellera Biologics (ABCL) Upgraded to Buy: Here's What You Should Know

AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024
ABCL

Business Wire

10 months ago

AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024

Down 57%, Is AbCellera Biologics a Buy on the Dip?
ABCL

Motley Fool

a year ago

Down 57%, Is AbCellera Biologics a Buy on the Dip?

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA
ABCL

CNW Group

a year ago

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku
ABCL

CNW Group

a year ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
ABCL

PR Newswire

a year ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store
ABCL

Business Wire

a year ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts
ABCL

AFP

a year ago

New Zealand scraps plan to tax livestock burps, farts

ABCL

Business Wire

a year ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility
ABCL

The Wall Street Journal

a year ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

UK Unemployment Rises in Sign Inflationary Pressures Cool
ABCL

Bloomberg

a year ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition
ABCL

Business Wire

a year ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus
ABCL

GlobeNewswire

a year ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23
ABCL

GlobeNewswire

a year ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?
ABCL

Simply Wall St.

a year ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May
ABCL

Reuters

a year ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'
ABCL

AFP

a year ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Enduring role of 'treasuring the past' hailed
ABCL

PR Newswire

a year ago

Enduring role of 'treasuring the past' hailed

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share
ABCL

GlobeNewswire

a year ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Italian energy company targets Britain for fleet of 20 mini-nukes
ABCL

The Telegraph

a year ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow
ABCL

Motley Fool

a year ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North
ABCL

AFP

a year ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss
ABCL

Simply Wall St.

a year ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations
ABCL

Simply Wall St.

a year ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns
ABCL

Simply Wall St.

a year ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
ABCL

Simply Wall St.

a year ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled
ABCL

Motley Fool

a year ago

3 Mistakes That Can Get Your Costco Membership Canceled

We're Not Very Worried About AbCellera Biologics' (NASDAQ:ABCL) Cash Burn Rate
ABCL

Simply Wall St.

a year ago

We're Not Very Worried About AbCellera Biologics' (NASDAQ:ABCL) Cash Burn Rate

AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
ABCL

Business Wire

a year ago

AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024

Earnings Release: Here's Why Analysts Cut Their AbCellera Biologics Inc. (NASDAQ:ABCL) Price Target To US$12.71
ABCL

Simply Wall St.

a year ago

Earnings Release: Here's Why Analysts Cut Their AbCellera Biologics Inc. (NASDAQ:ABCL) Price Target To US$12.71

AbCellera Biologics Inc. (NASDAQ:ABCL) Q1 2024 Earnings Call Transcript
ABCL

Insider Monkey

a year ago

AbCellera Biologics Inc. (NASDAQ:ABCL) Q1 2024 Earnings Call Transcript

ABCL

Thomson Reuters StreetEvents

a year ago

Q1 2024 Abcellera Biologics Inc Earnings Call

AbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcript
ABCL

Motley Fool

a year ago

AbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcript

Share on Social Networks: